A Study of the Pan-KRAS Inhibitor LY4066434 in Participants With KRAS Mutant Solid Tumors
Eli Lilly and Company
Eli Lilly and Company
Pfizer
TheRas, Inc., d/b/a BBOT (BridgeBio Oncology Therapeutics)
Pfizer
Eli Lilly and Company
Tesaro, Inc.
Toray Industries, Inc
Shanghai Junshi Bioscience Co., Ltd.
DEKA Biosciences
Jiangsu Hansoh Pharmaceutical Co., Ltd.
Eli Lilly and Company
Taiho Pharmaceutical Co., Ltd.
Emory University
Canadian Cancer Trials Group
Gilead Sciences